Metabolism - Clinical and Experimental
Volume 47, Supplement 1 , Pages 20-23, December 1998

Effects of angiotensin-converting enzyme inhibition on vascular remodeling of resistance vessels in hypertensive patients

  • Michael J. Mulvany

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Michael J. Mulvany, PhD, DMSc, Department of Pharmacology, Aarhus University, Universitetsparken 240, 8000 Aarhus C, Denmark.

Department of Pharmacology, University of Aarhus, Aarhus, Denmark

Abstract 

Essential hypertension is known to be associated with a decrease in the lumen diameter and an increase in the wall thickness to lumen diameter ratio of the resistance vessels. Recently, it has been clarified that this alteration does not necessarily involve vascular growth, but could be due to a rearrangement of the same amount of material, a phenomenon now termed “eutrophic remodeling.” These changes are found both in human essential hypertension and in animal models of genetic hypertension. Antihypertensive treatment with angiotensin-converting enzyme (ACE) inhibitors causes a dose-dependent regression of the media to lumen ratio in rats. Clinical studies have now confirmed these findings, showing that when previously untreated essential hypertensive patients are treated with the ACE inhibitor perindopril (PE), the abnormal structure of resistance vessels regresses toward normal values; in contrast, treatment with a β-blocker does not affect the abnormal vascular structure. The available evidence thus indicates that ACE inhibitors are able to normalize the abnormal resistance vessel structure in essential hypertension, and suggest that this effect may not only be dependent on their ability to reduce blood pressure. This review summarizes these findings, and discusses the extent to which this is desirable.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the Danish Medical Research Council and Danish Heart Foundation.

PII: S0026-0495(98)90366-3

Metabolism - Clinical and Experimental
Volume 47, Supplement 1 , Pages 20-23, December 1998